| Search |
| |
|
|
| UGA News Bureau |
|
|
Top
News Stories
|
| In
the News
|
| Master
Calendar
|
| Advisories
|
| All
News Releases
|
Columns
Faculty/staff newspaper |
| News
from Schools & Colleges |
| Media Resources |
| Campaign and election experts
|
| Back to School Features
|
| Media
contacts
|
| Experts
directory
|
| e-News |
| Put
UGA's top stories on your site |
| Special Reports |
Latest budget information
Arch News - August 7, 2009
Response to Board of Regents request for UGA budget plan
Arch News - July 22, 2009
Budget update
University of Georgia President Michael F. Adams gave a budget update to the UGA community during the April 23 meeting of the University Council at the Georgia Center for Continuing Education Conference Center and Hotel. A video presentation and talking points are available for viewing.
Arch News - April 22, 2009
Upcoming budget presentation
Arch News - April 10, 2009
Status of the FY10 state budget
UGA president provides budget update
University of Georgia President Michael F. Adams gave members of University Council an update on UGA’s budget Thursday, Dec. 4 in wake of recent actions by the University System of Georgia Board of Regents to help meet an anticipated directive from state officials to increase the budget cut to 8 percent from the current 6 percent.
View December 4, 2008 Budget Update
Public forum on University Budget
On Wednesday, Sept. 17, President Michael F. Adams and other senior university officials delivered a presentation about the impact of current economic challenges and responded to questions from the audience. Links to archived video of the first budget forum on Sept. 5.
View September 1, 2008 forum online →
View September 5, 2008 forum online →
President's talking points [pdf] →
UGA Fiscal Update [ppt] →
|
|
Information on the April 25 off-campus shooting
|
| Information on the national outbreak of H1N1 virus (commonly known as swine flu) |
| President's
speeches |
| UGA's
Master Plan |
| The
UGA Century |
40th
Anniversary of
UGA's Desegregation |
| UGA
Responds: 9/11 |
| Featured
Research |
| Commencement
Addresses |
| ARCHE Reports |
University System of Georgia
news publications |
| Legislative
Updates |
| The
System Supplement |
| Value-Added USG Serves Georgia |
| A Worthy Investment |
| UGA Open Records |
| Request procedure, form and FAQs |
| The Office of the Attorney General of Georgia |
| The Georgia Secretary of State Open Records |
| The Georgia First Amendment Foundation |
| Contact UGA Open Records Manager |
|
Researchers at University of Georgia provide first look at protein expression in Chagas Disease–causing parasites
Writer: Philip Lee Williams, 706/542-8501, phil@franklin.uga.edu
Contact: Rick Tarleton, 706/542-3362, tarleton@uga.edu
Jul 14, 2005, 14:00
Email this article
Printer friendly page
|
Athens, Ga. – Nearly 20 million people worldwide are infected with a parasitic ailment called Chagas Disease, and nearly a third of those will develop severe heart trouble. Although options for treatment are poor and there are no vaccines, a new study by scientists at the University of Georgia of proteins in the parasite that causes the disease may offer hope.
The first-ever global survey of protein expression in the four lifecycle stages of Trypanosoma cruzi, the parasite that causes the disease, could help lead to vaccine discovery and new drug targets, according to Rick Tarleton, a cellular biologist in UGA’s Center for Tropical and Emerging Global Diseases (CTEGD) and lead researcher.
“This work provides a first view into some of the complex biology of this organism,” said Tarleton. “It helps tell us which of its genes are expressed as proteins and in what stages.”
The research was published today in the journal Science. The study was conducted by Tarleton with colleagues James Atwood and Brent Weatherly, also of the CTEGD; Ron Orlando and his laboratory at UGA’s Complex Carbohydrate Research Center; and with help from Fred Opperdoes of Catholic University in Brussels.
The paper is part of a large section on parasite genomes in the current issue of Science. Tarleton is coauthor of the paper on the T. cruzi genome.
Chagas Disease is a pervasive problem in tropical climates. The disorder is named after Brazilian doctor Carlos Chagas who first discovered the parasite that causes the disease in 1910. While T. cruzi is also found in many other animals, including cats, dogs and rodents, it is unlikely that the parasite in those animals can be transmitted directly to humans. The disease in people is transmitted by insects that bite humans then defecate, passing the parasite into the blood stream when victims scratch the wound site or touch it and then touch a vulnerable mucus membrane site, such as the eyes.
Despite the widespread nature of the disease, available treatments are unreliable, and no vaccine against the parasite has ever been developed. That’s why Tarleton and his colleagues studied the T. cruzi “proteome” – proteins it expresses. The issue is complex, since the parasite has four lifecycle stages.
The research confirmed some of the predictions of gene expression in the just-completed gene map of T. cruzi. It also showed, for the first time, which genes express proteins in the four development stages.
“This provides a wealth of interesting biology we didn’t know before, but it also gives us ways to put the information to use,” said Tarleton. “What we found on stage specificity and abundance of protein expression provides new criteria for selecting vaccine targets. Additional information on the expression of large gene families may influence decisions on their utility as vaccine candidates.”
While the proteome analysis, in conjunction with the genome, provides new avenues for drug and vaccine discovery, limitations remain. Unlike the genome, which provides a comprehensive view of the entire organism, the proteomes are partial and preliminary.
“Unfortunately, current technology doesn’t allow for the easy detection of very low abundance proteins,” said Tarleton. “Also, it can look only at relative expression of proteins in different stages.”
Still, understanding how proteins work in T. cruzi is an important first step toward helping end the misery that plagues so many people. Researchers estimate that around 90 million people are at risk for Chagas Disease. In endemic areas, it is associated with other parasitic diseases, tuberculosis, HIV and malnutrition as a typical “social disease” among the rural poor.
Blood transfusions tainted with T. cruzi are also a serious problem in South America, and costs associated with control and treatment run into the billions of dollars each year. While the disease is rare in the United States, conditions in the far southeastern and southwestern parts of the country make it as least potentially susceptible to the disorder.
##
Note to editors: Tarleton is appearing on July 14 at a press conference in London to announce the findings in the parasite genome issue of Science. The easiest way to contact him for the next few days may be through e-mail.
Top of Page
|
|
